Greenbrook TMS Inc
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders. The company also offers Spravato,… Read more
Greenbrook TMS Inc (GBNHF) - Net Assets
Latest net assets as of June 2024: $-127.58 Million USD
Based on the latest financial reports, Greenbrook TMS Inc (GBNHF) has net assets worth $-127.58 Million USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($55.50 Million) and total liabilities ($183.08 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-127.58 Million |
| % of Total Assets | -229.89% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 465.8 |
Greenbrook TMS Inc - Net Assets Trend (2020–2023)
This chart illustrates how Greenbrook TMS Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Greenbrook TMS Inc (2020–2023)
The table below shows the annual net assets of Greenbrook TMS Inc from 2020 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-100.95 Million | -70.77% |
| 2022-12-31 | $-59.11 Million | -456.32% |
| 2021-12-31 | $16.59 Million | +475.27% |
| 2020-12-31 | $2.88 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Greenbrook TMS Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 16397299400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $126.14 Million | % |
| Total Equity | $-98.04 Million | 100.00% |
Greenbrook TMS Inc Competitors by Market Cap
The table below lists competitors of Greenbrook TMS Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Starwood European Real Estate Finance Ltd
LSE:SWEF
|
$105.78 |
|
Energroup Holdings Corp
PINK:ENHD
|
$106.45 |
|
CHAMPION BREWERIES PLC
XNSA:CHAMPION
|
$106.57 |
|
CANADA RARE EARTH
BE:P4XA
|
$106.79 |
|
Oro Blanco
SN:OROBLANCO
|
$105.65 |
|
VNTAD
PINK:VNTAD
|
$105.31 |
|
SVM UK Emerging Fund plc
LSE:SVM
|
$105.04 |
|
Aberforth Geared Value &
LSE:AGVI
|
$105.03 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Greenbrook TMS Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -56,334,715 to -98,036,209, a change of -41,701,494.
- Net loss of 48,914,062 reduced equity.
- New share issuances of 6,620,699 increased equity.
- Other factors increased equity by 591,869.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-48.91 Million | -49.89% |
| Share Issuances | $6.62 Million | +6.75% |
| Other Changes | $591.87K | +0.6% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Greenbrook TMS Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.24 | $0.01 | x |
| 2021-12-31 | $0.97 | $0.01 | x |
| 2022-12-31 | $-1.91 | $0.01 | x |
| 2023-12-31 | $-2.29 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Greenbrook TMS Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -66.29%
- • Asset Turnover: 1.44x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-262.06%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -905.40% | -68.78% | 0.63x | 20.94x | $-29.99 Million |
| 2021 | -142.85% | -47.42% | 0.72x | 4.19x | $-26.48 Million |
| 2022 | 0.00% | -131.19% | 0.94x | 0.00x | $-82.04 Million |
| 2023 | 0.00% | -66.29% | 1.44x | 0.00x | $-39.11 Million |
Industry Comparison
This section compares Greenbrook TMS Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Greenbrook TMS Inc (GBNHF) | $-127.58 Million | -905.40% | N/A | $105.74 |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |